StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Guided Therapeutics's price to sales ratio was 23.8× on Oct 19, 2026, against 180.7× a year earlier. Over the last 5 years it ranged from 0.1× to 381.1×, with a median of 110.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202623.8×−229.8
2025Dec 31, 2025253.6×+15.0
2024Dec 31, 2024238.7×+117.2
2023Dec 29, 2023121.4×+8.1
2022Dec 30, 2022113.3×−58.2
2021Dec 31, 2021171.6×–

More Guided Therapeutics figures

See a number that looks wrong?